Isolation and characterization of a bacteriophage targeting drug-resistant E. coli
Author Information
Author(s): Abozahra Rania, Shlkamy Dina, Abdelhamid Sarah M.
Primary Institution: Damanhour University
Hypothesis
The study aims to isolate and characterize a bacteriophage with lytic activity against multidrug-resistant E. coli.
Conclusion
The ɸEcM-vB1 bacteriophage shows high lytic activity against various multidrug-resistant E. coli isolates and is a promising candidate for phage therapy.
Supporting Evidence
- The bacteriophage exhibited high lytic activity against different MDR E. coli isolates.
- It showed stability over a wide pH and temperature range.
- The latent period of the phage was 5 minutes with an average burst size of 271.72 pfu/cell.
- Genomic analysis revealed susceptibility to digestion by EcoRI.
Takeaway
Scientists found a virus that can kill bad bacteria that don't respond to medicine, which could help treat infections.
Methodology
The study involved isolating the bacteriophage from sewage, testing its lytic activity, and analyzing its genomic and morphological characteristics.
Limitations
Whole genome sequencing of the ɸEcM-vB1 phage is not available.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website